Completed NA INTERVENTIONAL 2-arm NCT04781049

Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial

Transperineal Laser Ablation Of Prostate Versus Transurethral Prostate Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial

Sponsor: Elesta S.R.L.

Conditions Benign Prostatic Hyperplasia Benign Prostatic Hypertrophy Benign Prostatic Hypertrophy With Outflow Obstruction Prostate Hyperplasia

Interventions Trans-Perineal Laser Ablation of Prostate Trans-Urethral Resection of Prostate

Updated 5 times since 2021 Last updated: Feb 18, 2023 Started: Jan 1, 2021 Primary completion: Sep 20, 2021 Completion: Oct 6, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Benign Prostatic Hyperplasia and Benign Prostatic Hypertrophy and is currently completed. Elesta S.R.L. leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Oct 2021 — Mar 2023 [monthly]

Recruiting NA
Apr 2021 — Oct 2021 [monthly]

Recruiting NA

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Elesta S.R.L.
San Carlo di Nancy Hospital

Data source: San Carlo di Nancy Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Roma, Italy